Literature DB >> 33488497

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation.

Carolina Alquezar1, Shruti Arya1, Aimee W Kao1.   

Abstract

Post-translational modifications (PTMs) on tau have long been recognized as affecting protein function and contributing to neurodegeneration. The explosion of information on potential and observed PTMs on tau provides an opportunity to better understand these modifications in the context of tau homeostasis, which becomes perturbed with aging and disease. Prevailing views regard tau as a protein that undergoes abnormal phosphorylation prior to its accumulation into the toxic aggregates implicated in Alzheimer's disease (AD) and other tauopathies. However, the phosphorylation of tau may, in fact, represent part of the normal but interrupted function and catabolism of the protein. In addition to phosphorylation, tau undergoes another forms of post-translational modification including (but not limited to), acetylation, ubiquitination, glycation, glycosylation, SUMOylation, methylation, oxidation, and nitration. A holistic appreciation of how these PTMs regulate tau during health and are potentially hijacked in disease remains elusive. Recent studies have reinforced the idea that PTMs play a critical role in tau localization, protein-protein interactions, maintenance of levels, and modifying aggregate structure. These studies also provide tantalizing clues into the possibility that neurons actively choose how tau is post-translationally modified, in potentially competitive and combinatorial ways, to achieve broad, cellular programs commensurate with the distinctive environmental conditions found during development, aging, stress, and disease. Here, we review tau PTMs and describe what is currently known about their functional impacts. In addition, we classify these PTMs from the perspectives of protein localization, electrostatics, and stability, which all contribute to normal tau function and homeostasis. Finally, we assess the potential impact of tau PTMs on tau solubility and aggregation. Tau occupies an undoubtedly important position in the biology of neurodegenerative diseases. This review aims to provide an integrated perspective of how post-translational modifications actively, purposefully, and dynamically remodel tau function, clearance, and aggregation. In doing so, we hope to enable a more comprehensive understanding of tau PTMs that will positively impact future studies.
Copyright © 2021 Alquezar, Arya and Kao.

Entities:  

Keywords:  acetylation; glycation; glycosylation; methylation; phosphorylation; proteolysis; sumoylation; ubiquitination

Year:  2021        PMID: 33488497      PMCID: PMC7817643          DOI: 10.3389/fneur.2020.595532

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  307 in total

Review 1.  The proteasomal system.

Authors:  Tobias Jung; Betül Catalgol; Tilman Grune
Journal:  Mol Aspects Med       Date:  2009-04-14

2.  Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.

Authors:  M A Smith; S L Siedlak; P L Richey; R H Nagaraj; A Elhammer; G Perry
Journal:  Brain Res       Date:  1996-04-22       Impact factor: 3.252

3.  Caspase Activation in the Alzheimer's Disease Brain: Tortuous and Torturous.

Authors:  Troy T. Rohn; Robert A. Rissman; Elizabeth Head; Carl W. Cotman
Journal:  Drug News Perspect       Date:  2002-11

Review 4.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 5.  N-glycan and Alzheimer's disease.

Authors:  Yasuhiko Kizuka; Shinobu Kitazume; Naoyuki Taniguchi
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-04-29       Impact factor: 3.770

Review 6.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 7.  N-linked protein glycosylation in the ER.

Authors:  Markus Aebi
Journal:  Biochim Biophys Acta       Date:  2013-04-10

8.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

Authors:  Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Gerald W Hart; Cheng-Xin Gong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

9.  Assembly of Alzheimer-like filaments from full-length tau protein.

Authors:  R A Crowther; O F Olesen; M J Smith; R Jakes; M Goedert
Journal:  FEBS Lett       Date:  1994-01-10       Impact factor: 4.124

Review 10.  Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.

Authors:  James P Quinn; Nicola J Corbett; Katherine A B Kellett; Nigel M Hooper
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more
  37 in total

Review 1.  The Structure Biology of Tau and Clue for Aggregation Inhibitor Design.

Authors:  Dan Wang; Xianlong Huang; Lu Yan; Luoqi Zhou; Chang Yan; Jinhu Wu; Zhengding Su; Yongqi Huang
Journal:  Protein J       Date:  2021-08-17       Impact factor: 2.371

2.  Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease.

Authors:  Marcel V Alavi
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-08-13       Impact factor: 4.739

3.  Selective disruption of Drp1-independent mitophagy and mitolysosome trafficking by an Alzheimer's disease relevant tau modification in a novel Caenorhabditis elegans model.

Authors:  Sanjib Guha; Anson Cheng; Trae Carroll; Dennisha King; Shon A Koren; Sierra Swords; Keith Nehrke; Gail V W Johnson
Journal:  Genetics       Date:  2022-08-30       Impact factor: 4.402

Review 4.  Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases.

Authors:  Orkid Coskuner-Weber; Ozan Mirzanli; Vladimir N Uversky
Journal:  Biophys Rev       Date:  2022-06-08

5.  Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model.

Authors:  Isidro Ferrer; Pol Andrés-Benito; Karina Ausín; Paz Cartas-Cejudo; Mercedes Lachén-Montes; José Antonio Del Rio; Joaquín Fernández-Irigoyen; Enrique Santamaría
Journal:  Int J Mol Sci       Date:  2022-06-08       Impact factor: 6.208

6.  Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates.

Authors:  Melina Theoni Gyparaki; Arian Arab; Elena M Sorokina; Adriana N Santiago-Ruiz; Christopher H Bohrer; Jie Xiao; Melike Lakadamyali
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

Review 7.  Discovering the landscape of protein modifications.

Authors:  E Keith Keenan; Derek K Zachman; Matthew D Hirschey
Journal:  Mol Cell       Date:  2021-04-01       Impact factor: 17.970

Review 8.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

Review 9.  The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.

Authors:  Haiqiong Ye; Yue Han; Ping Li; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2022-03-24       Impact factor: 2.866

10.  Structure of Tau filaments in Prion protein amyloidoses.

Authors:  Grace I Hallinan; Md Rejaul Hoq; Manali Ghosh; Frank S Vago; Anllely Fernandez; Holly J Garringer; Ruben Vidal; Wen Jiang; Bernardino Ghetti
Journal:  Acta Neuropathol       Date:  2021-06-14       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.